A role for ras in v-Crk transformation

Cell Growth and Differentiation

Volumn 7, Issue 11, 1996, Pages 1443-1451

  Greulich, Heidi ^a,b   Hanafusa, Hidesaburo ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PHOSPHOTYROSINE; RAS PROTEIN; TYROSINE;

ANIMAL CELL; ARTICLE; AVIAN SARCOMA VIRUS; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFORMATION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY;

3T3 CELLS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL TRANSFORMATION, NEOPLASTIC; CHICK EMBRYO; ENZYME ACTIVATION; FIBROBLASTS; GENES, DOMINANT; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGOPEPTIDES; ONCOGENE PROTEIN V-CRK; ONCOGENES; PHOSPHORYLATION; PROTEIN ISOPRENYLATION; RAS PROTEINS; RETROVIRIDAE PROTEINS, ONCOGENIC; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TRANSFECTION; TYROSINE;

ANIMALIA; AVES; AVIAN SARCOMA VIRUS; GALLUS GALLUS;

EID: 0029914069     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Mayer, B., Hamaguchi, M., and Hanafusa, H. A novel viral oncogene with structural similarity to phospholipase C. Nature (Lond.), 332: 272-275, 1988.
2. Mayer, B., and Hanafusa, H. Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation. J. Virol., 64: 3581-3589, 1990.
3. Birge, R., Fajardo, J., Reichman, C., Shoelson, S., Songyang, Z., Cantley, L., and Hanafusa, H. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phospnorylated paxillin in CT10-transformed fibroblasts. Mol. Cell. Bid., 13: 4648-4656, 1993.
4. Sakai, R., Iwamatsu, A., Hirano, H., Ogawa, S., Tanaka, T., Mano, H., Yazaki, Y., and Hirai, H. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J., 13: 3748-3756, 1994.
5. Feller, S., Knudsen, B., and Hanafusa, H. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J., 13: 2341-2351, 1994.
6. Knudsen, B., Feller, S., and Hanafusa, H. Four proline-rich sequences of the guanine nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk. J. Biol. Chem., 269: 32781-32787, 1994.
7. Tanaka, S., Morishita, T., Hashimoto, Y., Hattori, S., Nakamura, S., Shibuya, M., Matuoka, K., Takenawa, T., Kurata, T., Nagashima, K., and Matsuda, M. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc. Natl. Acad. Sci. USA, 91: 3443-3447, 1994.
8. Gotoh, T., Hattori, S., Shun, N., Kitayama, H., Noda, M., Takai, Y., Kaibuchi, K., Matsui H., Hatase, O., Takahashi, H., Kurata, T., and Matsuda, M. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol., 15: 6746-6753, 1995.
9. ras-GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc. Natl. Acad. Sci. USA, 87: 7926-7929, 1990.
10. Batzer, A., Rotin, D., Urena, J., Skolnik, E., and Schlessinger, J. Hierarchy of binding sites for Grb2 and She on the epidermal growth factor receptor. Mol. Cell. Biol., 14: 5192-5201, 1994.
11. Batzer, A. G., Blaikie, P., Nelson, K., Schlessinger, J., and Margolis, B. The phosphotyrosine interaction domain of She binds an LXNPXY motif on the epidermal growth factor receptor. Mol. Cell. Biol., 15: 4403-4409, 1995.
12. McCormick, F. How receptors turn Ras on. Nature (Lond.), 363: 15-16, 1993.
13. McGlade, J., Cheng, A., Pelicci, G., Pelicci, P., and Pawson, T. She proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA, 89: 8869-8873, 1992.
14. Okabayashi, Y., Kido, Y., Okutani, T., Sugimoto, Y., Sakaguchi, K., and Kasuga, M. Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells. J. Biol. Chem., 269: 18674-18678, 1994.
15. Sasaoka, T., Langlois, W., Leitner, J., Draznin, B., and Olefsky, J. The signaling pathway coupling epidermal growth factor receptors to activation of p21ras. J. Biol. Chem., 269: 32621-32625, 1994.
16. Cai, H., Szeberenyi, J., and Cooper, G. M. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH-3T3 cells. Mol. Cell. Biol., 10: 5314-5323, 1990.
17. DeClue, J. E., Zhang, K., Redford, P., Vass, W. C., and Lowy, D. R. Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C-terminus. Mol. Cell. Biol., 11: 2819-2825, 1991.
18. Nori, M., Vogel, U. S., Gibbs, J. B., and Weber, M. Inhibition of v-src-induced transformation by a GTPase-activating protein. Mol. Cell. Biol., 11: 2812-2818, 1991.
19. Avruch, J., Zhang, X., and Kyriakis, J. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci., 19: 279-283, 1994.
20. Hipskind, R., Baccarini, M., and Nordheim, A. Transient activation of Raf-1, Mek, and Erk2 coincides kinetically with ternary complex factor phosphorylation and immediate-early gene promoter activity in vivo. Mol. Cell. Biol., 14: 6219-6231, 1994.
21. Marais, R., Wynne, J., and Treisman, R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional transactivation domain. Cell, 73: 381-393, 1993.
22. Nobes, C. D., and Hall, A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell, 81: 53-62, 1995.
23. Peppelenbosch, M. P., Qiu, R-G., de Vries-Smits, A. M. M., Tertoolen, L. G. J., de Laat, S. W., McCormick, F., Hall, A., Symons, M. H., and Bos, J. L. Rac mediates growth factor-induced arachidonic acid release. Cell, 81: 849-856, 1995.
24. Qiu, R-G., Chen, J., Kim, D., McCormick, F., and Symons, M. An essential role for Rac in Ras transformation. Nature (Lond.), 374: 457-459, 1995.
25. Ridley, A. J., and Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell, 70: 389-399, 1992.
26. Ridley, A. J., Paterson, H. F., Johnson, C. L., Diekmann, D., and Hall, A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell, 70: 401-410, 1992.
27. Hill, C. S., Wynne, J., and Treisman, R. The Rho family GTPases RhoA, Rad, and Cdc42Hs regulate transcriptional activation by SRF. Cell, 81: 1159-1170, 1995.
28. Coso, O. A., Chiariello, M., Yu, J-C., Teramoto, H., Crespo, P., Xu, N., Miki, T., and Gutkind, S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the Jnk/Sapk signaling pathway. Cell, 81: 1137-1146, 1995.
29. Minden, A., Lin, A., Claret, F-X., Abo, A., and Karin, M. Selective activation of the Jnk signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81: 1147-1157, 1995.
30. Blumer, K., and Johnson, G. Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci., 19: 236-240, 1994.
31. Burgering, B., and Bos, J. Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biochem. Sci., 20: 18-22, 1995.
32. Cox, A., Hisaka, M. M., Buss, J. E., and Der, C. J. Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein. Mol. Cell. Biol., 12: 2606-2615, 1992.
33. Garcia, A. M., Rowell, C., Ackermann, K., Kowalczyk, J. J., and Lewis, M. D. Peptidomimetic inhibitors of Ras farnesylation and function in whole cells. J. Biol. Chem., 268: 18415-18418, 1993.
34. Feig, L. A., and Cooper, G. M. Inhibition of NIH-3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol., 8: 3235-3243, 1988.
35. Jung, V., Wei, W., Ballester, R., Camonis, J., Mi, S., van Aelst, L., Wigler, M., and Broek, D. Two types of RAS mutants that dominantly interfere with activators of RAS. Mol. Cell. Biol., 14: 3707-3718, 1994.
36. ras. J. Biol. Chem., 268: 20232-20236, 1993.
37. Sanghera, J., Peter, M., Nigg, E., and Pelech, S. Immunological characterization of avian MAP kinases: evidence for nuclear localization. Mol. Biol. Cell., 3: 775-787, 1992.
38. Ward, Y., Gupta, S., Jensen, P., Wartmann, M., Davis, R., and Kelly, K. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature (Lond.), 367: 651-654, 1994.
39. Lebowitz, P. F., Davide, J. P., and Prendergast, G. C. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity. Mol. Cell. Biol., 15: 6613-6622, 1995.
40. Sun, H., Charles, C. H., Lau, L. F., and Tonks, N. K. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase/n vivo. Cell, 75: 487-493, 1993.
41. Ellis, C., Moran, M., McCormick, F., and Pawson, T. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature (Lond.), 343: 377-381, 1990.
42. Feller, S. M., Knudsen, B., and Hanafusa, H. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways. Oncogene, 10: 1465-1473, 1995.
43. Wu, X., Knudsen, B., Feller, S., Zheng, J., Sali, A., Cowburn, D., Hanafusa, H., and Kuriyan, J. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the amino-terminal SH3 domain of c-Crk. Structure, 3: 215-226, 1995.
44. Hempstead, B., Birge, R., Fajardo, J., Glassman, R., Mahadeo, D., Kraemer, R., and Hanafusa, H. Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways. Mol. Cell. Biol., 14: 1964-1971, 1994.
45. Tanaka, S., Hattori, S., Kurata, T., Nagashima, K., Fukui, Y., Nakamura, S., and Matsuda, M. Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells. Mol. Cell. Biol., 13: 4409-4415, 1993.
46. Matsuda, M., Tanaka, S., Nagata, S., Kojima, A., Kurata, T., and Shibuya, M. Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol., 12: 3482-3489, 1992.
47. Matsuda, M., Hashimoto, Y., Muroya, K., Hasegawa, H., Kurata, T., Tanaka, S., Nakamura, S., and Hattori, S. CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol. Cell. Biol., 14: 5495-5500, 1994.
48. Hanafusa, H. Rapid transformation of cells by Rous sarcoma virus. Proc. Natl. Acad. Sci. USA, 63: 318-325, 1969.
49. Kameshita, I., and Fujisawa, H. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem., 183: 139-143, 1989.